Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 15,300 | 79,300 | 59,900 | 28,400 | 7,000 |
| Depreciation Amortization | 22,800 | 83,700 | 62,100 | 42,900 | 22,000 |
| Income taxes - deferred | -10,300 | 27,900 | 1,800 | -1,600 | -700 |
| Accounts receivable | -16,600 | -12,500 | -11,100 | -26,100 | -11,900 |
| Accounts payable and accrued liabilities | 12,300 | 20,700 | 6,900 | 2,400 | 2,500 |
| Other Working Capital | -31,900 | 19,700 | 10,000 | -10,200 | -12,700 |
| Other Operating Activity | 18,500 | -7,200 | 7,500 | 27,200 | 15,400 |
| Operating Cash Flow | $10,100 | $211,600 | $137,100 | $63,000 | $21,600 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18,900 | -62,200 | -38,000 | -22,600 | -11,600 |
| Purchase Of Investment | N/A | -500 | N/A | N/A | N/A |
| Other Investing Activity | 100 | 6,300 | 5,400 | 1,000 | 0 |
| Investing Cash Flow | $-18,800 | $-56,400 | $-32,600 | $-21,600 | $-11,600 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -100,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | -7,400 | -5,400 | N/A | N/A |
| Common Stock Issued | 1,700 | 3,400 | 3,100 | 2,100 | 600 |
| Common Stock Repurchased | -11,300 | -32,700 | -20,300 | -13,100 | -2,900 |
| Financing Cash Flow | $-109,600 | $-36,700 | $-22,600 | $-11,000 | $-2,300 |
| Exchange Rate Effect | 1,100 | 7,900 | 1,000 | 2,900 | -900 |
| Beginning Cash Position | 210,000 | 83,600 | 83,600 | 83,600 | 83,600 |
| End Cash Position | 92,800 | 210,000 | 166,500 | 116,900 | 90,400 |
| Net Cash Flow | $-117,200 | $126,400 | $82,900 | $33,300 | $6,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 10,100 | 211,600 | 137,100 | 63,000 | 21,600 |
| Capital Expenditure | -18,900 | -62,200 | -38,000 | -22,600 | -11,600 |
| Free Cash Flow | -8,800 | 149,400 | 99,100 | 40,400 | 10,000 |